Article Archives

Filter

Hide Filter

  • Exhibition of Chromatography Columns at Pittcon® 2013

    Friday, May 10, 2013
    Technical Article
    Robert L. Stevenson, Ph.D.
    The technology and market for liquid chromatography columns continue to mature, with applications-specific columns on the rise. The chromatography columns target specific assays in the clinical ... read more

  • New Products at Pittcon® 2011

    Thursday, March 10, 2011
    Application Note
    Jeanely Hunt, MS, MBA
    The following includes some of the latest advances in laboratory instrumentation debuting at Pittcon® 2011. read more

  • Automatable Processes and Future Directions in Dried Blood Spot Analysis

    Friday, October 01, 2010
    Technical Article
    Chester Bowen
    The application of dried blood spots (DBS) for the storage, shipment, and quantification of xenobiotics has been gaining popularity in recent years. The invention of this technology can be attributed ... read more

  • Hyphenation: The Next Step in Thermal Analysis

    Friday, January 01, 2010
    Technical Article
    Kevin P. Menard Richard Spragg Greg Johnson Craig Sellman
    Thermal analysis, like most mature technologies, sees mostly incremental increases in its capabilities, such as the introduction of modulated temperature techniques in the early 1990s or the ... read more

  • Capillary-Channeled Polymer (C-CP) Fibers: A Novel Platform for Liquid-Phase Separations

    Wednesday, June 01, 2005
    Technical Article
    Dwella M. Nelson Rayman D. Stanelle Phil Brown R. Kenneth Marcus
    In spite of its relative maturity as a group of analytical methods, the field of liquid chromatography continues to evolve with regard to the development of new stationary phases that may provide ... read more

  • Using FAIMS to Increase Selectivity for LC-MS Analyses

    Wednesday, June 01, 2005
    Technical Article
    Roger Guevremont Beata Kolakowski
    In the development of many LC-MS methods, interferences are commonplace. In an environment in which data must stand up to rigorous scrutiny, such as in the pharmaceutical industry, selectivity of ... read more
  • <<
  • >>